Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pluda

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase II evaluation of thalidomide in patients with metastatic breast cancerS M Baidas, E P Winer, G F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancerW D Figg, W Dahut, P Duray, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase II evaluation of thalidomide in patients with metastatic breast cancerS M Baidas, E P Winer, G F Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcomaL Welles, M W Saville, J Lietzau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancerW D Figg, W Dahut, P Duray, et al.
Cancer|December 18, 2001
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neckJ E Tseng, B S Glisson, F R Khuri, et al.
Pageof 6